- Home
- COGT vs HY Comparison
COGT vs HY Comparison
Compare COGT & HY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COGT
- HY
- Stock Information
- Founded
- COGT 2014
- HY 1991
- Country
- COGT United States
- HY United States
- Employees
- COGT 205
- HY N/A
- Industry
- COGT Biotechnology: Pharmaceutical Preparations
- HY Construction/Ag Equipment/Trucks
- Sector
- COGT Health Care
- HY Industrials
- Exchange
- COGT Nasdaq
- HY Nasdaq
- Market Cap
- COGT 822.0M
- HY 735.1M
- IPO Year
- COGT 2018
- HY N/A
- Fundamental
- Price
- COGT $7.23
- HY $38.43
- Analyst Decision
- COGT Buy
- HY Strong Buy
- Analyst Count
- COGT 6
- HY 1
- Target Price
- COGT $15.20
- HY $70.00
- AVG Volume (30 Days)
- COGT 2.1M
- HY 55.5K
- Earning Date
- COGT 08-05-2025
- HY 08-05-2025
- Dividend Yield
- COGT N/A
- HY 3.72%
- EPS Growth
- COGT N/A
- HY N/A
- EPS
- COGT N/A
- HY 5.60
- Revenue
- COGT N/A
- HY $4,162,100,000.00
- Revenue This Year
- COGT N/A
- HY N/A
- Revenue Next Year
- COGT N/A
- HY $2.55
- P/E Ratio
- COGT N/A
- HY $6.91
- Revenue Growth
- COGT N/A
- HY N/A
- 52 Week Low
- COGT $3.72
- HY $34.13
- 52 Week High
- COGT $12.61
- HY $84.44
- Technical
- Relative Strength Index (RSI)
- COGT 65.40
- HY 38.89
- Support Level
- COGT $6.88
- HY $39.33
- Resistance Level
- COGT $7.83
- HY $42.89
- Average True Range (ATR)
- COGT 0.56
- HY 1.16
- MACD
- COGT 0.09
- HY -0.33
- Stochastic Oscillator
- COGT 78.17
- HY 8.79
About COGT Cogent Biosciences Inc.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
About HY Hyster-Yale Materials Handling Inc.
Hyster Yale Inc designs, engineers, manufactures, sells and services a comprehensive line of lift trucks, attachments, aftermarket parts and technology solutions marketed globally under the Hyster and Yale brand names. The Company has five segments, which include three in the lift truck business as discussed below, as well as Bolzoni S.p.A. (Bolzoni) and Nuvera Fuel Cells, LLC (Nuvera). Majority of revenue is from Lift Trucks. geographically operates in America, EMEA, JAPIC, maximum revenue from America.